Progress! Moms Applaud Biden/Harris Administration for Naming Meds Targeted for Price Cuts Through Medicare Negotiation
“Millions of moms, grandmothers, and families will be better off because Medicare is going to negotiate for lower prices for ten widely used heart disease, cancer, diabetes, and other medications. This is a triumph for the Biden/Harris administration, which fought hard for this, and it will provide a real boost for America’s families. The lower medication prices will improve the economic security of millions of people covered by Medicare who have long struggled to pay for the prescriptions they need, or made impossible trade-offs between food and shelter, on the one hand, and prescriptions on the other.
“For too long, big pharma’s price gouging has forced millions of people to ration their medications or go without them entirely, leading to life-threatening conditions. The Inflation Reduction Act (IRA) brought very welcome, long overdue progress by finally allowing Medicare to begin negotiating for lower drug prices. The Biden/Harris administration’s announcement today, naming the ten medications that we can expect to see price cuts on by 2026, helps realize that promise. Coupled with the $35 per month cap on insulin payments for seniors, this is very welcome progress – and something lawmakers should build on by allowing Medicare to negotiate for lower costs on more medications in years to come.
“America’s moms want lawmakers to build on and continue this progress. And we urge the pharmaceutical industry to drop its lawsuits designed to stop the drug price negotiation provisions of the IRA. It’s time, past time, we put people over profits.”